Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


29.03.2021

1 Acta Neurol Scand
2 Ann Neurol
2 BMC Neurol
2 Brain
3 Intern Med
1 J Immunol
1 J Nephrol
3 J Neuroimmunol
2 J Pediatr Endocrinol Metab
2 Kidney Int
2 Lancet Neurol
4 Mult Scler
1 N Engl J Med
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. KAVALIUNAS A, Danylaite Karrenbauer V, Hillert J
    Socioeconomic consequences of multiple sclerosis-A systematic literature review.
    Acta Neurol Scand. 2021 Mar 22. doi: 10.1111/ane.13411.
    PubMed         Abstract available


    Ann Neurol

  2. MIRO O, Porta-Etessam J, Gonzalez Del Castillo J
    Reply to: "COVID-19 and the Risk of GBS".
    Ann Neurol. 2021;89:846-847.
    PubMed        

  3. NOURBAKHSH B, Cordano C, Asteggiano C, Ruprecht K, et al
    Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.
    Ann Neurol. 2021 Mar 11. doi: 10.1002/ana.26062.
    PubMed         Abstract available


    BMC Neurol

  4. NETER E, Glass-Marmor L, Wolkowitz A, Lavi I, et al
    Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis.
    BMC Neurol. 2021;21:136.
    PubMed         Abstract available

  5. MACKENZIE N, Lopez-Coronel E, Dau A, Maloof D, et al
    Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    BMC Neurol. 2021;21:135.
    PubMed         Abstract available


    Brain

  6. VOGRIG A, Moritz CP, Camdessanche JP, Tholance Y, et al
    Unclear association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Mar 23. pii: 6181752. doi: 10.1093.
    PubMed        

  7. ONTANEDA D, Raza PC, Mahajan KR, Arnold DL, et al
    Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.
    Brain. 2021 Mar 23. pii: 6184142. doi: 10.1093.
    PubMed         Abstract available


    Intern Med

  8. AKEBO H, Sada R, Matsushita S, Ishimaru H, et al
    Lupus Aortitis Successfully Treated with Moderate-dose Glucocorticoids: A Case Report and Review of the Literature.
    Intern Med. 2020;59:2789-2795.
    PubMed         Abstract available

  9. KUME A, Kashiwakuma D, Kubodera A, Hayashi K, et al
    Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis.
    Intern Med. 2021 Mar 22. doi: 10.2169/internalmedicine.6956.
    PubMed         Abstract available

  10. HIRANO K, Itoi T, Sasahira N, Koyama H, et al
    Coexisting Type 1 Autoimmune Pancreatitis and Mixed-type Intraductal Papillary Mucinous Neoplasm.
    Intern Med. 2021 Mar 22. doi: 10.2169/internalmedicine.6514.
    PubMed         Abstract available


    J Immunol

  11. DURIGUTTO P, Macor P, Pozzi N, Agostinis C, et al
    Complement Activation and Thrombin Generation by MBL Bound to beta2-Glycoprotein I.
    J Immunol. 2020;205:1385-1392.
    PubMed         Abstract available


    J Nephrol

  12. PICCOLI GB
    A sad anniversary, one year of COVID-19 epidemics-in this issue: from COVID-19 to membranous nephropathy.
    J Nephrol. 2021 Mar 26. pii: 10.1007/s40620-021-01031.
    PubMed        


    J Neuroimmunol

  13. JUMAH M, Rahman F, Figgie M, Prasad A, et al
    COVID-19, HHV6 and MOG antibody: A perfect storm.
    J Neuroimmunol. 2021;353:577521.
    PubMed         Abstract available

  14. LAZAREVIC M, Djedovic N, Stanisavljevic S, Dimitrijevic M, et al
    Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies.
    J Neuroimmunol. 2021;354:577547.
    PubMed         Abstract available

  15. MORENO-ESCOBAR MC, Kataria S, Khan E, Subedi R, et al
    Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
    J Neuroimmunol. 2021;353:577523.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  16. NAZARI M, Shabani R, Dalili S
    The effect of concurrent resistance-aerobic training on serum cortisol level, anxiety, and quality of life in pediatric type 1 diabetes.
    J Pediatr Endocrinol Metab. 2020;33:599-604.
    PubMed         Abstract available

  17. KACAREVIC D, Bogavac-Stanojevic N, Spasojevic-Kalimanovska V, Bojanin D, et al
    Factors associated with oxidative stress status in pediatric patients with type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2020;33:591-598.
    PubMed         Abstract available


    Kidney Int

  18. FLOEGE J, Rovin BH
    The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy.
    Kidney Int. 2021;99:811-813.
    PubMed         Abstract available

  19. DELAFOSSE M, Ponlot E, Esteve E, Ghislain L, et al
    Personalized phospholipase A2 receptor antibody-driven rituximab treatment strategy in membranous nephropathy.
    Kidney Int. 2021;99:1023-1024.
    PubMed        


    Lancet Neurol

  20. LUNN MP
    Preventing expensive harms in Guillain-Barre syndrome.
    Lancet Neurol. 2021;20:249-251.
    PubMed        

  21. WALGAARD C, Jacobs BC, Lingsma HF, Steyerberg EW, et al
    Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
    Lancet Neurol. 2021;20:275-283.
    PubMed         Abstract available


    Mult Scler

  22. HARROUD A, Mitchell RE, Richardson TG, Morris JA, et al
    Childhood obesity and multiple sclerosis: A Mendelian randomization study.
    Mult Scler. 2021 Mar 22:13524585211001781. doi: 10.1177/13524585211001781.
    PubMed         Abstract available

  23. LEE LE, Vavasour IM, Dvorak A, Liu H, et al
    Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
    Mult Scler. 2021 Mar 22:13524585211001780. doi: 10.1177/13524585211001780.
    PubMed         Abstract available

  24. PORTACCIO E, Fonderico M, Hemmer B, Derfuss T, et al
    Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.
    Mult Scler. 2021 Mar 25:13524585211005339. doi: 10.1177/13524585211005339.
    PubMed         Abstract available

  25. CREE BA, Cohen JA, Reder AT, Tomic D, et al
    Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
    Mult Scler. 2021 Mar 26:13524585211000280. doi: 10.1177/13524585211000280.
    PubMed         Abstract available


    N Engl J Med

  26. BUTLER PC
    Supplying Insulin while Evading Immunity.
    N Engl J Med. 2021;384:967-969.
    PubMed        


    Proc Natl Acad Sci U S A

  27. RONIN E, Pouchy C, Khosravi M, Hilaire M, et al
    Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  28. VERGOOSSEN DLE, Plomp JJ, Gstottner C, Fillie-Grijpma YE, et al
    Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: